• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by CNO Financial Group Inc.

    5/8/24 5:04:35 PM ET
    $CNO
    Accident &Health Insurance
    Finance
    Get the next $CNO alert in real time by email
    FWP 1 tm2411933d5_fwp.htm FWP

     

    Filed Pursuant to Rule 433

    Registration No. 333-279143

    Issuer Free Writing Prospectus dated May 8, 2024

    Relating to Preliminary Prospectus Supplement dated May 8, 2024

     

    Strictly Confidential

     

    CNO Financial Group, Inc.

     

    Pricing Term Sheet

     

    $700,000,000 6.450% Senior Notes due 2034

     

    (the “Senior Notes Offering”)

     

    The information in this pricing term sheet relates to the Senior Notes Offering and should be read together with (i) the preliminary prospectus supplement dated May 8, 2024, including the documents incorporated by reference therein, and (ii) the related base prospectus dated May 6, 2024 each filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended.

     

    Issuer: CNO Financial Group, Inc.
       
    Securities Offered: 6.450% Senior Notes due 2034 (the “Notes”)
       
    Trade Date: May 8, 2024
       
    Settlement Date:* May 13, 2024 (T+3)
       
    Aggregate Principal Amount Offered: $700,000,000
       
    Maturity Date: Unless earlier redeemed, the Notes will mature on June 15, 2034.  See “Optional Redemption.”
       
    Price to Public: 99.668% of aggregate principal amount
       
    Yield to Maturity: 6.494%
       
    Benchmark Treasury: 4% due February 15, 2034
       
    Benchmark Treasury Yield: 4.494%
       
    Spread to Benchmark Treasury: T + 200 basis points
       
    Net Proceeds to Issuer: $693,126,000 (after deducting underwriting discounts and before estimated expenses)
       
    Use of Proceeds: The Issuer intends to use the net proceeds from the Senior Notes Offering, together with cash on hand, (i) for general corporate purposes, which may include the redemption, repurchase or repayment at or prior to maturity of its $500.0 million of 5.250% Senior Notes due 2025 and (ii) to pay fees, costs and expenses in connection with the foregoing and the Senior Notes Offering.

     

     

     

    Optional Redemption: Prior to March 15, 2034 (the date that is three months prior to the maturity date of the Notes), the Issuer may redeem the Notes, in whole or in part, at any time and from time to time, at a redemption price equal to the greater of (i) 100% of the principal amount of the Notes to be redeemed and (ii) a make-whole amount calculated as set forth in the preliminary prospectus supplement (Treasury Rate plus 30 basis points), plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. On and after March 15, 2034, the Issuer may redeem the Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest thereon to, but excluding, the redemption date.
       
    CUSIP / ISIN: 12621E AM5 / US12621EAM57
       
    Interest Payment Dates: June 15 and December 15 of each year
       
    Regular Record Dates: June 1 and December 1 of each year
       
    First Interest Payment Date: December 15, 2024
       
    Anticipated Ratings:** Baa3 / BBB- / BBB (Moody’s / S&P / Fitch)
       
    Joint Book-Running Managers:

    Goldman Sachs & Co. LLC

     

    RBC Capital Markets, LLC

     

    Barclays Capital Inc.

     

    KeyBanc Capital Markets Inc.

       
    Co-Managers:

    Drexel Hamilton, LLC

     

    Loop Capital Markets LLC

     

    *It is expected that delivery of the Notes will be made against payment therefore on or about May 13, 2024, which is the third business day following the date hereof (such settlement cycle being referred to as “T+3”). Under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in two business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes prior to the second business day before the delivery of the Notes hereunder will be required, by virtue of the fact that the Notes initially will settle in T+3, to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement and should consult their own advisors.

     

    **Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision, suspension or withdrawal at any time. Each credit rating should be evaluated independently of any other credit rating.

     

    - 1 -

     

     

    The Issuer has filed a registration statement, including a prospectus and preliminary prospectus supplement, with the U.S. Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. Before you invest, you should read the preliminary prospectus supplement and accompanying prospectus in that registration statement and other documents the Issuer has filed with the SEC for more complete information about the Issuer and the Senior Notes Offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and preliminary prospectus supplement if you request it by contacting Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282-2198, by phone at (866) 471-2526 or by email at [email protected]; RBC Capital Markets, LLC, Attention: DCM Transaction Management/Scott Primrose, 200 Vesey Street, 8th Floor, New York, NY 10281, by phone at (866) 375-6829 or by email at [email protected]; Barclays Capital Inc., by phone at (888) 603-5847; or KeyBanc Capital Markets Inc., Attention: Fixed Income Syndicate, 127 Public Square, 7th Floor, Cleveland, Ohio 44114 or by phone at (866) 227-6479.

     

    Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system.

     

    - 2 -

    Get the next $CNO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNO

    DatePrice TargetRatingAnalyst
    12/15/2025$47.00Hold → Buy
    Jefferies
    1/23/2025$38.00Market Perform
    BMO Capital Markets
    4/16/2024$29.00Neutral → Overweight
    Piper Sandler
    1/4/2024$24.00 → $26.00In-line → Underperform
    Evercore ISI
    6/29/2023Mkt Perform
    Raymond James
    9/13/2022$25.00Outperform
    RBC Capital Mkts
    1/26/2022$25.00Hold
    Jefferies
    1/7/2022$27.00 → $28.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $CNO
    SEC Filings

    View All

    SEC Form 13F-HR filed by CNO Financial Group Inc.

    13F-HR - CNO Financial Group, Inc. (0001224608) (Filer)

    2/12/26 2:44:53 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial Group Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CNO Financial Group, Inc. (0001224608) (Filer)

    2/11/26 4:17:26 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CNO Financial Group, Inc. (0001224608) (Filer)

    2/5/26 4:16:47 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    $CNO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CNO Financial upgraded by Jefferies with a new price target

    Jefferies upgraded CNO Financial from Hold to Buy and set a new price target of $47.00

    12/15/25 9:01:39 AM ET
    $CNO
    Accident &Health Insurance
    Finance

    BMO Capital Markets initiated coverage on CNO Financial with a new price target

    BMO Capital Markets initiated coverage of CNO Financial with a rating of Market Perform and set a new price target of $38.00

    1/23/25 7:38:32 AM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded CNO Financial from Neutral to Overweight and set a new price target of $29.00

    4/16/24 7:43:21 AM ET
    $CNO
    Accident &Health Insurance
    Finance

    $CNO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CNO Financial Group Declares $0.17 Quarterly Dividend and Announces Virtual Annual Meeting Date

    Director Nina Henderson to retire CARMEL, Ind., Feb. 11, 2026 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) announced today that its Board of Directors has declared a quarterly cash dividend of $0.17 per share on the company's common shares. The dividend will be payable March 24, 2026, to shareholders of record at the close of business on March 10, 2026. The company announced that its annual meeting of shareholders will be held via a virtual, live webcast at 8:00 a.m. ET on May 12, 2026. Holders of record at the close of business on March 16, 2026, will be able to parti

    2/11/26 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial Group Reports Fourth Quarter and Full Year 2025 Results

    CARMEL, Ind., Feb. 5, 2026 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) today reported its fourth quarter and full year 2025 financial results: Achieved, and in most cases exceeded, all 2025 guidance metrics.Fourth quarter 2025 net income was $93 million, or $0.95 per diluted share, and net operating income(1) was $143 million, or $1.47 per diluted share.Full year 2025 net income was $229 million, or $2.30 per diluted share, and net operating income(1) was $439 million, or $4.40 per diluted share. Return on equity (ROE) of 8.9%; Operating ROE of 11.4%, excluding signif

    2/5/26 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial Group Announces Senior Leadership Promotions

    Steve Janoson promoted to Senior Vice President, Direct and Independent Distribution;Rachel Spehler promoted to Senior Vice President, Deputy General Counsel and Secretary CARMEL, Ind., Jan. 21, 2026 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) announced today the promotions of Steve Janoson to Senior Vice President, Direct and Independent Distribution and Rachel Spehler to Senior Vice President, Deputy General Counsel and Secretary. Both promotions are effective immediately. Janoson most recently served as Vice President, Direct and Independent Distribution, a positio

    1/21/26 5:00:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    $CNO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, Consumer Division Goldberg Scott L. was granted 26,071 units of Common Stock, covered exercise/tax liability with 8,185 units of Common Stock and was granted 15,800 units of Restricted Stock Units, increasing direct ownership by 19% to 214,524 units (SEC Form 4)

    4 - CNO Financial Group, Inc. (0001224608) (Issuer)

    2/12/26 6:00:58 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    Amendment: President, Consumer Division Goldberg Scott L. sold $433,182 worth of Common Stock (17,095 units at $25.34) and exercised 17,095 units of Common Stock at a strike of $16.42 (SEC Form 4)

    4/A - CNO Financial Group, Inc. (0001224608) (Issuer)

    2/12/26 5:41:53 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    Chief Executive Officer Bhojwani Gary C. covered exercise/tax liability with 64,164 units of Common Stock, was granted 81,600 units of Restricted Stock Units and was granted 152,542 units of Common Stock, increasing direct ownership by 87% to 365,904 units (SEC Form 4)

    4 - CNO Financial Group, Inc. (0001224608) (Issuer)

    2/12/26 5:29:42 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    $CNO
    Leadership Updates

    Live Leadership Updates

    View All

    CNO Financial Group Appoints Linda Gibson to its Board of Directors

    CARMEL, Ind., Jan. 15, 2026 /PRNewswire/ -- CNO Financial Group (NYSE:CNO) announced today that its board of directors has appointed Linda Gibson as a Director, effective immediately. Gibson is the former Chairperson and Chief Executive Officer of PGIM Quantitative Solutions, which is the quantitative equity and multi-asset specialist within Prudential Financial's global investment management business. Gibson's appointment increases the size of the CNO Board to 10 directors. "We are pleased to welcome Linda to the CNO Board of Directors," said Board Chair Dan Maurer. "With mor

    1/15/26 5:00:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    David Foss, Former President and CEO of Jack Henry, Appointed to WEX Board of Directors

    WEX (NYSE:WEX), the global commerce platform that simplifies the business of running a business, today announced that David Foss has been appointed to its Board of Directors, effective November 3, 2025. Mr. Foss's appointment is the result of an extensive search process with the assistance of an independent recruitment firm. Mr. Foss brings over 30 years of leadership experience in financial services and financial technology to WEX, most recently as Chief Executive Officer of Jack Henry & Associates (NASDAQ:JKHY). He also has relevant public company board experience, currently serving as Chair of Jack Henry and as a Director of CNO Financial Group (NYSE:CNO). "We are pleased to welcome

    10/29/25 4:30:00 PM ET
    $CNO
    $JKHY
    $WEX
    Accident &Health Insurance
    Finance
    EDP Services
    Technology

    CNO Financial Group Announces Voting Results from 2025 Annual Meeting of Shareholders

    CARMEL, Ind., May 8, 2025 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) announced that at the company's annual meeting held earlier today, its shareholders: Elected nine directors (Gary C. Bhojwani, Archie M. Brown, David B. Foss, Mary R. (Nina) Henderson, Adrianne B. Lee, Daniel R. Maurer, Chetlur S. Ragavan, Steven E. Shebik, and Jessica A. Turner) to each serve a one-year term expiring at next year's annual meeting.Approved, by non-binding advisory vote, the executive compensation of the company's named executive officers as disclosed in the proxy statement for the a

    5/8/25 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    $CNO
    Financials

    Live finance-specific insights

    View All

    CNO Financial Group Reports Fourth Quarter and Full Year 2025 Results

    CARMEL, Ind., Feb. 5, 2026 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) today reported its fourth quarter and full year 2025 financial results: Achieved, and in most cases exceeded, all 2025 guidance metrics.Fourth quarter 2025 net income was $93 million, or $0.95 per diluted share, and net operating income(1) was $143 million, or $1.47 per diluted share.Full year 2025 net income was $229 million, or $2.30 per diluted share, and net operating income(1) was $439 million, or $4.40 per diluted share. Return on equity (ROE) of 8.9%; Operating ROE of 11.4%, excluding signif

    2/5/26 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial Group to Release Fourth Quarter and Full Year 2025 Results on February 5, 2026

    CARMEL, Ind., Jan. 20, 2026 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) will report results for the fourth quarter and full year ended December 31, 2025 after the market closes on Thursday, February 5, 2026. The company will host a conference call to discuss results at 11:00 a.m. Eastern Time on Friday, February 6, 2026. Participate by Dial-InTo participate, please register here. Upon registering, you will be provided with call details and a registrant ID that is used to track attendance on the conference call. Reminders will also be sent to registered participants vi

    1/20/26 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    CNO Financial Group Declares $0.17 Quarterly Dividend

    CARMEL, Ind., Nov. 12, 2025 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) announced today that its Board of Directors has declared a quarterly cash dividend of $0.17 per share on the company's common shares. The dividend will be payable December 23, 2025, to shareholders of record at the close of business on December 10, 2025. About CNO Financial GroupCNO Financial Group, Inc. (NYSE:CNO) secures the future of middle-income America. CNO provides life and health insurance, annuities, financial services and workforce benefits solutions through our family of brands, includi

    11/12/25 4:30:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    $CNO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CNO Financial Group Inc. (Amendment)

    SC 13G/A - CNO Financial Group, Inc. (0001224608) (Subject)

    2/12/24 5:53:46 PM ET
    $CNO
    Accident &Health Insurance
    Finance

    SEC Form SC 13G filed by CNO Financial Group Inc.

    SC 13G - CNO Financial Group, Inc. (0001224608) (Subject)

    2/9/24 11:33:46 AM ET
    $CNO
    Accident &Health Insurance
    Finance

    SEC Form SC 13G/A filed by CNO Financial Group Inc. (Amendment)

    SC 13G/A - CNO Financial Group, Inc. (0001224608) (Subject)

    2/14/23 12:24:22 PM ET
    $CNO
    Accident &Health Insurance
    Finance